These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15380142)

  • 41. Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review.
    Hughes C; Elgasim M; Layfield R; Atiomo W
    Hum Reprod; 2006 Nov; 21(11):2766-75. PubMed ID: 16936300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
    Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
    Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
    Wood JR; Nelson-Degrave VL; Jansen E; McAllister JM; Mosselman S; Strauss JF
    Physiol Genomics; 2005 Feb; 20(3):233-43. PubMed ID: 15598877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
    Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ
    Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of genes and environment in the etiology of PCOS.
    Diamanti-Kandarakis E; Kandarakis H; Legro RS
    Endocrine; 2006 Aug; 30(1):19-26. PubMed ID: 17185788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
    Wiltgen D; Furtado L; Kohek MB; Spritzer PM
    Gynecol Endocrinol; 2007 Mar; 23(3):173-8. PubMed ID: 17454172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome.
    Choi SW; Gu BH; Ramakrishna S; Park JM; Baek KH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):85-8. PubMed ID: 19427093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
    Ferk P; Teran N; Gersak K
    Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
    Abbott DH; Barnett DK; Bruns CM; Dumesic DA
    Hum Reprod Update; 2005; 11(4):357-74. PubMed ID: 15941725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis.
    Ioannidis A; Ikonomi E; Dimou NL; Douma L; Bagos PG
    Mol Genet Metab; 2010 Feb; 99(2):174-83. PubMed ID: 19926323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.
    Urbanek M; Woodroffe A; Ewens KG; Diamanti-Kandarakis E; Legro RS; Strauss JF; Dunaif A; Spielman RS
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6623-9. PubMed ID: 16091490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional genomics of PCOS: from GWAS to molecular mechanisms.
    McAllister JM; Legro RS; Modi BP; Strauss JF
    Trends Endocrinol Metab; 2015 Mar; 26(3):118-24. PubMed ID: 25600292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetic basis of polycystic ovary syndrome.
    Xita N; Georgiou I; Tsatsoulis A
    Eur J Endocrinol; 2002 Dec; 147(6):717-25. PubMed ID: 12457445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics of the polycystic ovary syndrome.
    Kosova G; Urbanek M
    Mol Cell Endocrinol; 2013 Jul; 373(1-2):29-38. PubMed ID: 23079471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCOS in 2015: New insights into the genetics of polycystic ovary syndrome.
    Azziz R
    Nat Rev Endocrinol; 2016 Feb; 12(2):74-5. PubMed ID: 26729036
    [No Abstract]   [Full Text] [Related]  

  • 59. The polycystic ovary syndrome: what does insulin resistance have to do with it?
    Ben-Shlomo I
    Reprod Biomed Online; 2003; 6(1):36-42. PubMed ID: 12626141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a male phenotype in polycystic ovary syndrome families?
    Legro RS
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1307-9. PubMed ID: 11117676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.